Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Jury Awards $1.7M for Cancer from Actos, But Defense Verdict Entered September 30, 2013 Irvin Jackson Add Your Comments In the second trial out of more than 3,000 Actos lawsuits pending nationwide, a Maryland jury found that Takeda Pharmaceutical’s failed to adequately warn physicians about the risk of bladder cancer from their popular diabetes drug and awarded nearly $1.77 million in damages. However, under an uncommon Maryland law, a defense verdict was entered because the jury also found that the plaintiff contributed to his cancer diagnosis. Following three weeks of trial and two days of deliberations in the Circuit Court of Maryland for Baltimore City, a jury found that Takeda’s negligent failure to warn about the the possibility of bladder cancer from Actos side effects was a substantial factor in Diep An’s cancer diagnosis and death. However, they also found that Mr. An failed to exercise reasonable care for his own health, which invalidated the damage award under Maryland’s contributory negligence law. Diep An began using Actos in 2007 and was diagnosed with bladder cancer in September 2011, which ultimately resulted in his death from the disease in January 2012. The family filed a wrongful death lawsuit against Takeda, alleging that the drug maker failed to adequately warn consumers or the medical community about the link between Actos and bladder cancer. Learn More About Actos Lawsuit Side effects of Actos may increase the risk of bladder cancer. Lawsuits are pending nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Actos Lawsuit Side effects of Actos may increase the risk of bladder cancer. Lawsuits are pending nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to allegations raised during the trial, Takeda knew or should have known about risk of bladder cancer before the drug was introduced in 1999. However, information about the cancer risk was not added to the warning label until 2011, after An had been using the medication for several years. At trial, Takeda’s attorneys defended the safety of their popular diabetes drug and argued that An’s prior smoking habit contributed to his death. Under Maryland’s pure contributory negligence law, if a plaintiffs’ own negligence contributes in any way to the harm claimed, they are barred from obtaining any recovery. Although the Maryland jury found that Takeda negligently failed to adequately warn about the known risk of bladder cancer with Actos use, and that this failure to warn Mr. An’s physicians was a substantial factor in causing his cancer, the jury’s award of $1,765,000.00 in compensatory damages was invalidated, including $625,000 awarded to Mr. An’s estate, $540,000 awarded to his wife for loss of consortium and $600,000 awarded to his three children for wrongful death. The damage award was overturned because the jury also found that Mr. An “failed to exercise reasonable and ordinary care for his own health and safety.” However, Maryland is one of only a handful of states that still apply pure contributory negligence in tort cases, which means that the damage award likely would have stood if it went to trial in another state. Actos Bladder Cancer Lawsuits Actos (pioglitazone) is a type 2 diabetes drug that has been used by millions of Americans, but thousands of product liability lawsuits have been filed nationwide over the past three years after concerns emerged about a connection between bladder cancer and Actos in September 2010. The An family’s case was at least the second Actos trial to reach a jury in the United States, with a California jury awarding $6.5 million in damages from Actos in April, involving a case brought by Jack Cooper. However, the judge presiding over that case subsequently reversed that damage award after key expert witness testimony was thrown out. In the federal court system, more than 2,500 complaints are centralized for coordinated handling in an Actos MDL, or multidistrict litigation, which is centralized before U.S. District Judge Rebecca H. Doherty in the Western District of Louisiana. A small group of cases in the MDL are being prepared for early trial dates, which are expected to begin in January 2014. In complex pharmaceutical litigation, where a large number of lawsuits are brought involving similar injuries caused by a prescription medication, these early trials are often used to gauge how juries are likely to respond to certain evidence and testimony that is likely to be repeated throughout the litigation. Therefore, despite the two defense verdicts obtained by Takeda, the fact that both juries found that the drug maker failed to adequately warn about the Actos bladder cancer risk and awarded substantial damages may facilitate further settlement negotiations. Following the early trial dates in the federal MDL, if an Actos settlement agreement or other resolution for the litigation is not reached, Takeda could begin facing hundreds of individual trial dates in courts throughout the United States. Tags: Actos, Actos Bladder Cancer, Cancer, Diabetes, Diabetes Drug, Maryland, Takeda Pharmaceuticals, Wrongful Death Image Credit: | More Actos Lawsuit Stories Actos Bladder Cancer Warnings Updated by FDA to Add New Study Data Reviewed December 13, 2016 Bladder Cancer Risk with Actos Highlighted in a New Study April 5, 2016 Actos Side Effects May Increase Risk of Bone Fractures, Weight Gain: Study March 1, 2016 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (Posted: 2 days ago) A product liability lawsuit filed against Novo Nordisk accuses the drug maker of failing to provide adequate warnings of Ozempic side effects, like stomach paralysis. MORE ABOUT: OZEMPIC LAWSUITOzempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)Ozempic Delayed Gastric Emptying Led to Stomach Paralysis: Lawsuit (03/27/2025)Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (03/21/2025) More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (Posted: 3 days ago) Nearly a dozen different cosmetics companies face more than 12,000 hair relaxer lawsuits, involving claims that chemical straighteners caused women to develop uterine cancer, endometrial cancer, ovarian cancer and other injuries. MORE ABOUT: HAIR RELAXER LAWSUITUterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025) Paraquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (Posted: 4 days ago) Lawyers involved in Paraquat Parkinson’s disease lawsuits pending in the federal court system indicate that they have reached an agreement to settle many of the claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSAppeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)Farmers Exposed to Certain Pesticides Face an Increased Risk of Rheumatoid Arthritis (12/11/2024)
Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (Posted: 2 days ago) A product liability lawsuit filed against Novo Nordisk accuses the drug maker of failing to provide adequate warnings of Ozempic side effects, like stomach paralysis. MORE ABOUT: OZEMPIC LAWSUITOzempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)Ozempic Delayed Gastric Emptying Led to Stomach Paralysis: Lawsuit (03/27/2025)Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (03/21/2025)
More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (Posted: 3 days ago) Nearly a dozen different cosmetics companies face more than 12,000 hair relaxer lawsuits, involving claims that chemical straighteners caused women to develop uterine cancer, endometrial cancer, ovarian cancer and other injuries. MORE ABOUT: HAIR RELAXER LAWSUITUterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)
Paraquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (Posted: 4 days ago) Lawyers involved in Paraquat Parkinson’s disease lawsuits pending in the federal court system indicate that they have reached an agreement to settle many of the claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSAppeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)Farmers Exposed to Certain Pesticides Face an Increased Risk of Rheumatoid Arthritis (12/11/2024)